¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"reference dose"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
¼³¸í
maximum accumulation dose
ÃÖ´ë ÃàÀû·®
maximum tolerance dose
ÃÖ´ë ³»¿ë·®, ÃÖ´ë °ßµõ ¼±·®
mean effective dose
50% À¯È¿·®
mean lethal dose
50% Ä¡»ç·®
mean target dose
Æò±Õ Ç¥Àû ¼±·®
metered-dose inhaler
methacholine (¸ÞŸÄݸ°
°·ÂÇÑ Äݸ° ÀÛµ¿Á¦·Î¼ ¾Æ¼¼Æ¿Äݸ°°ú °°Àº ÀÛ¿ëÀÌ ÀÖ´Ù.
midbreast dose
À¯¹æ Áß¾Ó Á¶»ç¼±·®
minimal dose
ÃÖ¼Ò·®
minimum dose
ÃÖ¼Ò·®
minimum hemolytic dose
ÃÖ¼Ò ¿ëÇ÷·®
minimum inhibitory dose
ÃÖ¼Ò ¾ïÁ¦·®
minimum reacting dose
ÃÖ¼Ò ¹ÝÀÀ·®
optimal dose
ÃÖÀû·®, ÀûÁ¤·®
oral dose
±¸° ¿ë·®
organ tolerance dose
±â°ü Çã¿ë·®, Àå±â Çã¿ë·®
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½